The Pan-American Journal of Ophthalmology (Jan 2022)

Neuroretinitis as the only manifestation of Lyme disease: A case report

  • Mateus Pimenta Arruda,
  • Marcio Augusto Nogueira Costa,
  • Jacqueline Coblentz,
  • Miguel N Burnier

DOI
https://doi.org/10.4103/pajo.pajo_31_22
Journal volume & issue
Vol. 4, no. 1
pp. 38 – 38

Abstract

Read online

Lyme disease is a multisystemic infection caused by the spirochete bacterium Borrelia burgdorferi, transmitted by the tick of the genus Ixodes sp. and has three stages: primary, secondary, and tertiary. Ocular involvement is possible in any of these stages. Neuroretinitis is a rare manifestation. It is recommended that the diagnosis be performed by serology using an immunoenzymatic test, and confirmed by the Western Blot test. The recommended therapy is doxycycline 100 mg 12/12 h or 200 mg once a day for 14 days to 21 days or amoxicillin 500 mg three times a day for 14–21 days. We herein present a patient who had neuroretinitis related to a previous diagnosis of Lyme disease. The presence of neuroretinitis in a setting of Lyme disease represents a very uncommon manifestation of this particular infection.

Keywords